You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

Article metrics

Article menu
Infectious diseases
Protocol
ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

 

Online download statistics by month:

Online download statistics by month: December 2021 to November 2023

AbstractFullPdf
Dec 2021935936149
Jan 202258558949
Feb 202220821238
Mar 202215415231
Apr 202216817544
May 202210610734
Jun 2022666645
Jul 2022605624
Aug 2022959115
Sep 2022676416
Oct 2022576032
Nov 2022615919
Dec 2022444113
Jan 2023565023
Feb 202339369
Mar 2023565410
Apr 2023323013
May 2023433911
Jun 202333349
Jul 2023454419
Aug 202343429
Sep 202325253
Oct 2023454118
Nov 2023545020
Total30773053653